PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97511117 |
Filing Date: 07/20/2022 |
Input Field |
Entered |
SERIAL NUMBER | 97511117 |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT18\IMAGEOUT 18\975\111\97511117\xml1 \ APP0002.JPG |
SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
LITERAL ELEMENT | Solar Biotech |
COLOR MARK | YES |
COLOR(S) CLAIMED (If applicable) |
The color(s) black and green is/are claimed as a feature of the mark. |
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of the word Solar in black, but for a green stylized O, located above the word Biotech in green. |
PIXEL COUNT ACCEPTABLE | YES |
PIXEL COUNT | 400 x 400 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Solar Biotech, Inc. |
*MAILING ADDRESS | 5516 Industrial Park Rd. |
*CITY | Norton |
*STATE (Required for U.S. applicants) |
Virginia |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
24273-4033 |
PHONE | 540-400-9453 |
*EMAIL ADDRESS | XXXX |
WEBSITE ADDRESS | http://www.solarbiotech.com |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 001 |
*IDENTIFICATION | Bioproducts or chemical compounds produced by biotechnological or syn-bio manufacturing processes for use in food, cosmetics, and other applications. |
FILING BASIS | SECTION 1(b) |
INTERNATIONAL CLASS | 042 |
*IDENTIFICATION | Consulting services in the field of biotechnology; development of new technology in the fields of synthetic biology and industrial biotechnology; development of new technology for others in the fields of synthetic biology and industrial biotechnology; consulting services in the fields of pharmaceutical research and development, laboratory testing, diagnostics, pharmacogenetics and genetic science; research and development in the pharmaceutical and biotechnology fields. |
FILING BASIS | SECTION 1(b) |
ATTORNEY INFORMATION | |
NAME | Michele L. Mayberry |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | NEW RIVER VALLEY IP LAW, PC |
STREET | PO Box 10944 |
CITY | BLACKSBURG |
STATE | Virginia |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 24062 |
PHONE | 540-605-8050 |
EMAIL ADDRESS | michele.mayberry@nrviplaw.com |
CORRESPONDENCE INFORMATION | |
NAME | Michele L. Mayberry |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | michele.mayberry@nrviplaw.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | NOT PROVIDED |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 2 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 700 |
*TOTAL FEES PAID | 700 |
SIGNATURE INFORMATION | |
SIGNATURE | /Vera Maximenko/ |
SIGNATORY'S NAME | Vera Maximenko |
SIGNATORY'S POSITION | Sr. VP of Development & Operations |
SIGNATORY'S PHONE NUMBER | 530-400-9453 |
DATE SIGNED | 07/19/2022 |
SIGNATURE METHOD | Sent to third party for signature |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97511117 |
Filing Date: 07/20/2022 |
The applicant's current Correspondence Information: |
Michele L. Mayberry |
PRIMARY EMAIL FOR CORRESPONDENCE: michele.mayberry@nrviplaw.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT
PROVIDED Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|